logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. The European Randomized Study of Screening for Prostate Cancer : An update : Review of current data impacting early detection guidelines for prostate cancer.

    Article, Communication - En anglais

    American Cancer Society Workshop. Phoenix, Arizona (USA), 1997/03/10.

    BACKGROUND

    A consensus meeting on screening and global strategy for prostate carcinoma, held in Antwerp in 1994, determined the willingness among European cancer prevention centers to pursue vigorously the collaborative formation of a multinational randomized screening trial.

    This trial was to be named the European Randomized Study of Screening for Prostate Cancer (ERSPC).

    METHODS

    During the years prior to that meeting, several feasibility trials were conducted in Antwerp and Rotterdam to evaluate the pitfalls and problems of a randomized procedure for population screening.

    Today, five centers in five European countries share their study work and results via the ERSPC, and others are lining up to join this massive effort.

    Regular meetings and specific work groups enable the research centers to compare their data, because the trial methodology differs slightly from one center to another.

    RESULTS

    However, a common work strategy and analysis of the data has recently been reached, and the first study results of the trial (evaluating 180,000 men over a 10-year screening period) are expected by the year 2007.

    CONCLUSIONS

    A randomized trial of prostate carcinoma screening is set up in Europe currently with five participating centers from five countries.

    First overall effect results of regular screening are expected after a 10-year period of follow-up.

    Mots-clés Pascal : Carcinome, Prostate, Homme, Dépistage, Prévention, Programme sanitaire, Méthodologie, Randomisation, Echelon international, Europe, Tumeur maligne

    Mots-clés Pascal anglais : Carcinoma, Prostate, Human, Medical screening, Prevention, Sanitary program, Methodology, Randomization, International scope, Europe, Malignant tumor

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 98-0027648

    Code Inist : 002B14D02. Création : 17/04/1998.